Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
May 2021
Historique:
received: 16 09 2020
accepted: 16 11 2020
pubmed: 23 1 2021
medline: 14 7 2021
entrez: 22 1 2021
Statut: ppublish

Résumé

A 53-year-old female patient with acute myeloid leukemia developed severe chronic graft vs host disease (cGVHD) of the oral mucosa after allogeneic hematopoietic stem cell transplantation with leukoplakia and relapsing oral squamous cell carcinoma (SCC) of the tongue. cGVHD needed long-lasting immunosuppressive therapy; SCC was treated with radiation and surgery. Acute myeloid leukemia remained in complete remission. The patient developed a myositis with pain of all muscles as well as paraparesis with elevated creatine kinase and C-reactive protein and detection of antiskeletal muscle autoantibodies 3500 days after hematopoietic stem cell transplantation. No other clinical features of chronic GVHD were apparent at this time. Symptoms disappeared after treatment with corticosteroids but relapsed while tapering. Weekly therapy with the B-cell-depleting antibody rituximab was started and administered for 6 weeks. Symptoms disappeared again but partly returned after some weeks, so therapy with azathioprine was started. During therapy with azathioprine slow tapering of corticosteroids was possible and clinical symptoms remained absent. Here we present a case report and review of the literature on alloimmune myositis as paraneoplastic complication of an oral SCC of the tongue after severe chronic GVHD or as late manifestation of chronic GVHD itself.

Identifiants

pubmed: 33478746
pii: S0041-1345(20)32906-7
doi: 10.1016/j.transproceed.2020.11.010
pii:
doi:

Substances chimiques

Autoantibodies 0
Immunosuppressive Agents 0
C-Reactive Protein 9007-41-4

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1365-1368

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Pascal Woelfinger (P)

Hematology, Oncology and Pneumology, UCT, University Medical Center Mainz, Mainz, Germany. Electronic address: pascal.woelfinger@unimedizin-mainz.de.

Beate Hauptrock (B)

Hematology, Oncology and Pneumology, UCT, University Medical Center Mainz, Mainz, Germany.

Oliver Kriege (O)

Hematology, Oncology and Pneumology, UCT, University Medical Center Mainz, Mainz, Germany.

Wilfried Wagner (W)

Maxillofacial Surgery, UCT, University Medical Center Mainz, Mainz, Germany.

Julia Heider (J)

Maxillofacial Surgery, UCT, University Medical Center Mainz, Mainz, Germany.

Andreas Schwarting (A)

Rheumatology UCT, University Medical Center Mainz, Mainz, Germany.

Frank Birklein (F)

Neurology, University Medical Center Mainz, Mainz, Germany.

Matthias Theobald (M)

Hematology, Oncology and Pneumology, UCT, University Medical Center Mainz, Mainz, Germany.

Eva Maria Wagner-Drouet (EM)

Hematology, Oncology and Pneumology, UCT, University Medical Center Mainz, Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH